COPOLYMERIZATION AND DETERMINATION OF MONOMER REACTIVITY RATIOS OF DL-LACTIDE WITH 3-BENZYLOXYMETHYL-1,4-DIOXANE-2,5-DIONE*
Papers|Updated:2021-06-21
|
COPOLYMERIZATION AND DETERMINATION OF MONOMER REACTIVITY RATIOS OF DL-LACTIDE WITH 3-BENZYLOXYMETHYL-1,4-DIOXANE-2,5-DIONE*
COPOLYMERIZATION AND DETERMINATION OF MONOMER REACTIVITY RATIOS OF DL-LACTIDE WITH 3-BENZYLOXYMETHYL-1,4-DIOXANE-2,5-DIONE*
高分子科学(英文版)2002年20卷第5期 页码:413-417
Affiliations:
Author bio:
Funds:
DOI:
中图分类号:
纸质出版:2002-10-20
Accepted:
Scan QR Code
COPOLYMERIZATION AND DETERMINATION OF MONOMER REACTIVITY RATIOS OF DL-LACTIDE WITH 3-BENZYLOXYMETHYL-1,4-DIOXANE-2,5-DIONE*[J]. 高分子科学(英文版), 2002,20(5):413-417.
COPOLYMERIZATION AND DETERMINATION OF MONOMER REACTIVITY RATIOS OF DL-LACTIDE WITH 3-BENZYLOXYMETHYL-1,4-DIOXANE-2,5-DIONE*[J]. 2002, 20(5): 413-417.
COPOLYMERIZATION AND DETERMINATION OF MONOMER REACTIVITY RATIOS OF DL-LACTIDE WITH 3-BENZYLOXYMETHYL-1,4-DIOXANE-2,5-DIONE*[J]. 高分子科学(英文版), 2002,20(5):413-417.DOI:
COPOLYMERIZATION AND DETERMINATION OF MONOMER REACTIVITY RATIOS OF DL-LACTIDE WITH 3-BENZYLOXYMETHYL-1,4-DIOXANE-2,5-DIONE*[J]. 2002, 20(5): 413-417.DOI:
COPOLYMERIZATION AND DETERMINATION OF MONOMER REACTIVITY RATIOS OF DL-LACTIDE WITH 3-BENZYLOXYMETHYL-1,4-DIOXANE-2,5-DIONE*
The copolymerization of DL-LA and 3-BMG was carried out in bulk with Stannous 2-ethylhexanoate as thecatalyst. A series of copolymers with pendant protected groups were obtained and characterized by 1H-NMR and GPCanalysis. The monomer reactivity ratios were evaluated by the Fineman-Ross method and the Kelen-Tudos method and foundto be rBMG = 1.96 and rLA = 0.37
respectively.
Abstract
The copolymerization of DL-LA and 3-BMG was carried out in bulk with Stannous 2-ethylhexanoate as thecatalyst. A series of copolymers with pendant protected groups were obtained and characterized by 1H-NMR and GPCanalysis. The monomer reactivity ratios were evaluated by the Fineman-Ross method and the Kelen-Tudos method and foundto be rBMG = 1.96 and rLA = 0.37
respectively.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.